The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Maintenance Drug Treatment of Panic Disorder: I. Results of a Prospective, Placebo-Controlled Comparison of Alprazolam and Imipramine
Abstract
One hundred six patients diagnosed according to DSM-III as suffering from agoraphobia with panic disorder, panic disorder with limited phobic avoidance, or uncomplicated panic disorder entered an acute 8-week treatment phase. Patients who improved received an additional 6 months' maintenance treatment. Significantly more patients treated with alprazolam than with imipramine hydrochloride or placebo remained in therapy and experienced panic attack and phobia relief during the acute treatment phase. During the maintenance phase, neither tolerance nor daily dose increase was observed. All patients who completed the maintenance phase (27 in the alprazolam group, 11 in the imipramine group, and 10 in the placebo group) were panic free at the end of 8 months of study treatment. Alprazolam therapy was effective and well tolerated at a mean daily dose of 5.7 mg. Imipramine hydrochloride (175 mg/d) also produced significant panic relief but was associated with poor patient acceptance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In another study of patients with panic disorder, neither anxiolytic tolerance nor daily dose increase was observed after 8 weeks of alprazolam treatment, with continued efficacy at 6 months (Schweizer et al., 1993).”
From A Review of Alprazolam Use, Misuse, and Withdrawal (2018) · cites this paper as Schweizer et al., 1993
In the citing paper
“However, interestingly, both chlordiazepoxide and diazepam were found to be ineffective in preventing alprazolam withdrawal symptoms in 2 separate cases (Schweizer et al., 1993; Sachdev et al., 2014).”
From A Review of Alprazolam Use, Misuse, and Withdrawal (2018) · cites this paper as Schweizer et al., 1993
In the citing paper
“In patients with panic disorder, neither anxiolytic tolerance nor daily dose increase was observed after 8 weeks of alprazolam treatment with continued efficacy [67].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [67]
Citations
Cites
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
Brief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801
Treatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal Symptoms
Sheehan, D. V. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780140053006 · Cited by 729
Ballenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Sanderson, W. C. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810020059010 · Cited by 492
Rickels, K. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290060008 · Cited by 384
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610023151403 · Cited by 369
IN-VIVO DEMONSTRATION OF REDUCED BENZODIAZEPINE RECEPTOR BINDING IN HUMAN EPILEPTIC FOCI
Savic, I., Roland, P., Sedvall, G., Persson, A., Pauli, S., & Widen, L. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92468-3 · Cited by 367
SAFTEE: a technique for the systematic assessment of side effects in clinical trials.
Levine, J., & Schooler, N. (1986) · PubMed · Cited by 362
Cited by
A meta-analysis of treatment outcome for panic disorder
Gould, R. A., Ott, M. W., & Pollack, M. H. (1995) · Clinical Psychology Review · doi:10.1016/0272-7358(95)00048-8 · Cited by 520
The diagnosis and management of benzodiazepine dependence
Ashton, H. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165594.60434.84 · Cited by 455
Mitte, K. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.05.003 · Cited by 396
The elevated T-maze as an experimental model of anxiety
Graeff, F. G., Ferreira Netto, C., & Zangrossi Jr, H. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00024-4 · Cited by 391
Griffiths, R. R., & Weerts, E. M. (1997) · Psychopharmacology · doi:10.1007/s002130050422 · Cited by 260
Metadata
- Authors
- Schweizer, E.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Schweizer, Edward
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1993-01-01
- Volume
- 50
- Issue
- 1
- Pages
- 51
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2019194252
- Cited by
- 120
- References
- 60
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 4 · 2017: 1 · 2016: 3 · 2015: 3 · 2013: 1 · 2012: 4
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH-08957)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- panic disorder, agoraphobia, maintenance therapy, alprazolam, imipramine, benzodiazepines, tricyclic antidepressants, drug tolerance, medication adherence, panic attacks, phobic avoidance
- MeSH terms
- Adult, Agoraphobia, Alprazolam, Anxiety Disorders, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Imipramine, Male, Middle Aged, Patient Dropouts, Placebos, Prospective Studies, Severity of Illness Index, Panic Disorder, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Maintenance Drug Treatment of Panic Disorder: I. Results of a Prospective, Placebo-Controlled Comparison of Alprazolam and Imipramine. https://app.cochat.ai/papers/10.1001/archpsyc.1993.01820130053009
- The paper
- Schweizer, E. (1993). Maintenance Drug Treatment of Panic Disorder: I. Results of a Prospective, Placebo-Controlled Comparison of Alprazolam and Imipramine. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1993.01820130053009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.